Rocket Pharmaceuticals's total assets for Q1 2025 were $471.07M, a decrease of -10.73% from the previous quarter. RCKT total liabilities were $58.93M for the fiscal quarter, a -8.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.